Y-Intercept (HK)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-45,999
Closed -$597K 1447
2024
Q2
$597K Buy
+45,999
New +$597K 0.03% 740
2023
Q4
Sell
-31,247
Closed -$349K 1345
2023
Q3
$349K Buy
+31,247
New +$349K 0.03% 701
2023
Q2
Sell
-5,436
Closed -$220K 1382
2023
Q1
$220K Buy
5,436
+1,051
+24% +$42.5K 0.03% 919
2022
Q4
$204K Buy
+4,385
New +$204K 0.03% 829